Imprimir…

Esta buscando: Clinical+Instruments


7 990  results were found

Refinar resultados Ordenado por
SearchResultCount:"7990"

Sort Results

Vista lista Vista Extendida (Nueva)

Valore los resultados de su búsqueda

Image Unavailable-BOSSBS-4807R-A555

Anti-ATXN3L Rabbit Polyclonal Antibody (Alexa Fluor® 555)

Numero del catalogo: (BOSSBS-4807R-A555)
Proveedor: Bioss
Descripción: Defects in ATXN3 are the cause of spinocerebellar ataxia type 3 (SCA3) ; also known as Machado-Joseph disease (MJD). Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA3 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. The molecular defect in SCA3 is the a CAG repeat expansion in ATXN3 coding region. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.
UOM: 1 * 100 µl
Image Unavailable-BOSSBS-4807R-CY5.5

Anti-ATXN3L Rabbit Polyclonal Antibody (Cy5.5®)

Numero del catalogo: (BOSSBS-4807R-CY5.5)
Proveedor: Bioss
Descripción: Defects in ATXN3 are the cause of spinocerebellar ataxia type 3 (SCA3) ; also known as Machado-Joseph disease (MJD). Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA3 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. The molecular defect in SCA3 is the a CAG repeat expansion in ATXN3 coding region. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.
UOM: 1 * 100 µl

Nueva transparencia para los clientes europeos

¿Ha observado nuestra nueva visibilidad mejorada de la ubicación del stock en el paso de adquisición?

Más información

Mejora para las ubicaciones de stock

Image Unavailable-BOSSBS-4807R-CY5

Anti-ATXN3L Rabbit Polyclonal Antibody (Cy5®)

Numero del catalogo: (BOSSBS-4807R-CY5)
Proveedor: Bioss
Descripción: Defects in ATXN3 are the cause of spinocerebellar ataxia type 3 (SCA3) ; also known as Machado-Joseph disease (MJD). Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA3 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. The molecular defect in SCA3 is the a CAG repeat expansion in ATXN3 coding region. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.
UOM: 1 * 100 µl
Product Image-MODU371213

Lancetas de sangre de seguridad, VITREX® STERILANCE® Lite III

Numero del catalogo: (MODU371213)
Proveedor: Vitrex Medical A/S
Descripción: Lancetas de seguridad para la glucosa en sangre y otros<i> in vitro</i> pruebas de diagnóstico.
UOM: 1 * 100 UN

New Product


Product Image-113-9408

VWR®, Cleanroom Socks, Non ESD, Disposable

Proveedor: VWR Collection
Descripción: These disposable socks are made of polyester filament yarn.

Certificados Environmentally Preferable

Image Unavailable-APOSBISN0153-10MG

IPI-549

Proveedor: Apollo Scientific
Descripción: IPI-549 is a selective phosphoinositide-3-kinase (PI3K)-γ inhibitor with IC50 of 16 nM as an immuno-oncology clinical candidate.

Product Image-1.04095.0250

Glicerina ≥99.5% para microscopia de fluorescencia, Sigma-Aldrich®

Numero del catalogo: (1.04095.0250)
Proveedor: Merck
Descripción: Glycerol is an aqueous mounting agent for preparation permanent slides of material of human origin or fluorescence microscopy. 100 ml are sufficient for approx. 200 - 300 applications. The mounting agent is an IVD registered product and CE certified, thus can be used for clinical diagnostic purposes.
UOM: 1 * 250 mL

FDS


Product Image-EE222

Chromogenic media for colourful microbial detection, CHROMagar™

Proveedor: CHROMAGAR
Descripción: Chromogenic technology applied to culture media allows you to differentiate and easily identify, inside one single plate, the growth of different microorganisms.

Product Image-113-8225

VWR® Overalls, SMS

Proveedor: VWR Collection
Descripción: These durable, anti-static overalls are made of breathable, soft SMS, a spunbonded fabric with a unique tri-laminate construction, that offers a high tensile strength and toughness, plus provides a barrier to fluids and particulates.

Image Unavailable-BOSSBS-7974R-CY3

Anti-ATXN2 Rabbit Polyclonal Antibody (Cy3®)

Numero del catalogo: (BOSSBS-7974R-CY3)
Proveedor: Bioss
Descripción: The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ATX2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. ATX2 is caused by expansion of a CAG repeat in the coding region of ATX2. Longer expansions result in earlier onset of the disease. There are four named isoforms.
UOM: 1 * 100 µl
Image Unavailable-BOSSBS-7974R-CY5.5

Anti-ATXN2 Rabbit Polyclonal Antibody (Cy5.5®)

Numero del catalogo: (BOSSBS-7974R-CY5.5)
Proveedor: Bioss
Descripción: The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ATX2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. ATX2 is caused by expansion of a CAG repeat in the coding region of ATX2. Longer expansions result in earlier onset of the disease. There are four named isoforms.
UOM: 1 * 100 µl
Image Unavailable-G4507-5G

Giemsa tincione, grado técnico used as a blood stain, Sigma-Aldrich®

Proveedor: SIGMA ALDRICH MICROSCOPY
Descripción: Giemsa stain is a versatile differential stain that is widely used in hematology for blood and bone marrow specimens, clinical cytology specimens, bacteriology, histological biopsies, and tumor samples. Giemsa's staining solution is composed of methylene blue, azure, and eosin. It is a major histological stain due to its unique staining of chromatin, nuclear membranes, and cytoplasmic elements. The stain is frequently used in combination with other dye solutions: May-Grünwald’s solution for Pappenheim (MGG) and Wright-Giemsa.

Certificados

Image Unavailable-BNC470674-100

Anti-KRT10 Mouse Monoclonal Antibody (CF647) [clone: LH2]

Proveedor: Biotium
Descripción: This MAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts.

Image Unavailable-BNUB0844-100

Anti-KRT10 Mouse Monoclonal Antibody (Purified) [clone: KRT10/844]

Proveedor: Biotium
Descripción: This MAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts.

Image Unavailable-BNCB0674-100

Anti-KRT10 Mouse Monoclonal Antibody (Biotin) [clone: LH2]

Proveedor: Biotium
Descripción: This MAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts.

Image Unavailable-BNC880844-100

Anti-KRT10 Mouse Monoclonal Antibody (CF488A) [clone: KRT10/844]

Proveedor: Biotium
Descripción: This MAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts.

Consulta de precio
El stock para este material es limitada pero puede estar disponible en un almacén cerca de usted. Por favor, asegúrese de que ha iniciado sesión en la web para que el stock disponible se puede mostrar. Si el call sigue apareciendo y usted necesita ayuda, por favor llámenos al 902 222 897 o por email en webshop.es@avantorsciences.com.
El stock para este material es limitada pero puede estar disponible en un almacén cerca de usted. Por favor, asegúrese de que ha iniciado sesión en la web para que el stock disponible se puede mostrar. Si el call sigue apareciendo y usted necesita ayuda, por favor llámenos al 902 222 897 o por email en webshop.es@avantorsciences.com.
Este producto se trata de un artículo regulado sometido a normativa que restringe su venta. Si procede, nos pondremos en contacto con usted para solicitarle la licencia o declaración de uso necesaria para poder proceder al suministro del producto.
Este producto se trata de un artículo regulado sometido a normativa que restringe su venta.
Si procede, nos pondremos en contacto con usted para solicitarle la licencia o declaración de uso necesaria para poder proceder al suministro del producto.
Este producto ha sido bloqueado por su organización. Por favor, pónganse en contacto con su departamento de compras para obtener más información.
El producto original ya no está disponible. Su sustituto se muestra a continuación.
El producto(s) marcados con este símbolo están descatalogados - se venden hasta acabar stock. Pueden encontrar alternativas buscando con el número de catálogo VWR listado arriba. Si necesita más ayuda, por favor llame al Servicio de atención al cliente de VWR al 902.222.897.
81 - 96 of 7 990
no targeter for Bottom